Page last updated: 2024-08-26

bismuth and B-Cell Lymphoma

bismuth has been researched along with B-Cell Lymphoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robotis, J; Rokkas, T; Tsiodras, S1
Friesen, C; Hormann, I; Leib, O; Marx, S; Miltner, E; Moreno, J; Roscher, M1
Brechbiel, MW; Goldenberg, DM; Jackson, TJ; Mattes, MJ; Michel, RB; Rosario, AV1
Apostolidis, C; Bacher, K; de Gelder, V; De Vos, F; Dierckx, R; Janssens, A; Morgenstern, A; Offner, F; Philippé, J; Slegers, G; Thierens, H; Vandenbulcke, K1

Other Studies

4 other study(ies) available for bismuth and B-Cell Lymphoma

ArticleYear
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
    Helicobacter, 2018, Volume: 23, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell; Metronidazole; Middle Aged; Organometallic Compounds; Rabeprazole; Salicylates

2018
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor o
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:11

    Topics: Antibodies, Monoclonal; Apoptosis; bcl-X Protein; Bismuth; Caspases; Cell Line, Tumor; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Radioimmunotherapy; Radioisotopes; Sialic Acid Binding Ig-like Lectin 3; X-Linked Inhibitor of Apoptosis Protein

2013
Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74.
    Nuclear medicine and biology, 2003, Volume: 30, Issue:7

    Topics: Animals; Antibodies; Antigens, Differentiation, B-Lymphocyte; Bismuth; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Radiation; Histocompatibility Antigens Class II; Lymphoma, B-Cell; Mice; Mice, SCID; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Survival; Tissue Transplantation; Transplantation, Heterologous; Treatment Outcome

2003
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study.
    Nuclear medicine communications, 2004, Volume: 25, Issue:11

    Topics: Alpha Particles; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Apoptosis; Bismuth; Humans; Lymphoma, B-Cell; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptors, Cytokine; Rituximab; Treatment Outcome; Tumor Cells, Cultured

2004